|1.||Nakano, Ryosuke: 4 articles (11/2006 - 07/2002)|
|2.||Kurosaki, Eiji: 4 articles (11/2006 - 07/2002)|
|3.||Shibasaki, Masayuki: 4 articles (11/2006 - 07/2002)|
|4.||Shimaya, Akiyoshi: 4 articles (11/2006 - 07/2002)|
|5.||Shikama, Hisataka: 2 articles (03/2003 - 07/2002)|
|6.||Suzuki, Takayuki: 2 articles (03/2003 - 07/2002)|
|7.||Kajikawa, Satoru: 1 article (11/2006)|
|8.||Ida, Motoko: 1 article (03/2003)|
|9.||Yoshida, Shigeru: 1 article (03/2003)|
|10.||Momose, Kazuhiro: 1 article (07/2002)|
08/01/2006 - "These results indicate that YM440 ameliorates hepatic, but not peripheral insulin resistance in ZF rats. "
08/01/2006 - "The aim of this study is to examine the effects of YM440 on hepatic and peripheral insulin resistance in Zucker fatty (ZF) rats using the euglycemic-hyperinsulinaemic clamp technique. "
11/07/2006 - "YM440 has been shown to counteract insulin resistance in diabetic rodent models. "
08/01/2006 - "The novel hypoglycemic agent YM440 improves hepatic insulin resistance in obese Zucker fatty rats."
03/01/2000 - "The novel hypoglycemic agent YM440 normalizes hyperglycemia without changing body fat weight in diabetic db/db mice."
03/01/2000 - "YM440 ameliorates hyperglycemia without changing PPARgamma activity, adipocyte differentiation, or fat weight. "
03/01/2003 - "Prior studies showed that YM440 ameliorated hyperglycemia in diabetic mice without affecting body fat weight or PPARgamma transactivation. "
07/01/2002 - "These results indicate that glucose intolerance in obese rats was associated with decreased hepatic glycogenesis and YM440 improved the intolerance by normalizing glycogen metabolism."
07/01/2002 - "We studied the role of hepatic glycogenesis in glucose intolerance after glucose loading in obese Zucker rats and the effects of YM440 ((Z)-1,4-bis[4-[(3,5-dioxo-1,2,4-oxadiazolidin-2-yl)methyl]phenoxy]but-2-ene) on it. "